| Autor: |
Kolamunnage-Dona, Ruwanthi, Kamarudin, Adina Najwa |
| Zdroj: |
Research Methods in Medicine & Health Sciences; March 2021, Vol. 2 Issue: 2 p51-60, 10p |
| Abstrakt: |
The performance of a biomarker is defined by how well the biomarker is capable to distinguish between healthy and diseased individuals. This assessment is usually based on the baseline value of the biomarker; the value at the earliest time point of the patient follow-up, and quantified by ROC (receiver operating characteristic) curve analysis. However, the observed baseline value is often subjected to measurement error due to imperfect laboratory conditions and limited machine precision. Failing to adjust for measurement error may underestimate the true performance of the biomarker, and in a direct comparison, useful biomarkers could be overlooked. We develop a novel approach to account for measurement error when calculating the performance of the baseline biomarker value for future survival outcomes. We adopt a joint longitudinal and survival data modelling formulation and use the available longitudinally repeated values of the biomarker to make adjustment of the measurement error in time-dependent ROC curve analysis. Our simulation study shows that the proposed measurement error-adjusted estimator is more efficient for evaluating the performance of the biomarker than estimators ignoring the measurement error. The proposed method is illustrated using Mayo Clinic primary biliary cirrhosis (PBC) study. |
| Databáze: |
Supplemental Index |
| Externí odkaz: |
|
